• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNeximmune
    Picture of Neximmune logo

    NEXI — Neximmune News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      -$2.42m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NEXI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NEXI Dividends
    All News

    NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

    Picture of Neximmune logoNeximmune
    12/02/2021 09:00
    NASDAQ TRADE HALT  NEXI.O  REASON NOT AVAILABLE AT 04:00 AM
    

    Recent news on Neximmune

    See all news
    • Brief: Neximmune Appointed Albert Marchio As Interim CFO

      05/04/2024 22:40
    • Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022

      02/02/2024 18:31
    • Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024

      19/01/2024 21:49
    • Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq

      01/12/2023 19:24
    • Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting

      19/10/2023 14:24

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.